Data Governance, Privacy, and Ethics

Published

Jun 2026

ID: CLIN-004
Type: Foundations
Audience: Clinical data learners, analysts, informatics teams, health researchers
Theme: Clinical data systems must protect people before they produce analysis

Clinical data is not ordinary data.

It describes people, illnesses, treatments, risks, encounters, and outcomes.

This means clinical data systems must be designed with more than technical accuracy in mind.

They must also protect patients, respect permissions, preserve trust, and prevent misuse.

A clinical dataset may be clean, well-structured, and statistically useful, but still unsafe or inappropriate to analyze if governance, privacy, and ethics are weak.

This chapter introduces the governance layer that sits underneath every responsible clinical data workflow.

Learning Objectives

By the end of this chapter, you should be able to:

Explain why clinical data governance is part of analysis readiness.
Distinguish privacy, confidentiality, security, consent, and ethical use.
Recognize common risks in patient-level clinical datasets.
Describe practical safeguards such as de-identification, access control, audit trails, and data minimization.
Understand why clinical interpretation must remain cautious, contextual, and accountable.

Why Governance Comes Before Analysis

Clinical data analysis often begins with a practical question:

Can we use these data to answer this clinical question?

Before answering that, a safer question must come first:

Are we allowed to use these data for this purpose, and can we do so responsibly?

Governance determines whether data use is appropriate.

It defines:

who can access the data,
what they are allowed to do with it,
which identifiers must be removed or protected,
how outputs should be reviewed,
how risks to patients and communities should be minimized,
and who is accountable if something goes wrong.

In a CDI clinical data system, governance is not an administrative afterthought.

It is part of the analytical pipeline.

Governance as a System Layer

A clinical data system should treat governance as a visible layer between raw data and analysis.

Clinical Data Source
        ↓
Governance and Permissions
        ↓
Privacy and Security Controls
        ↓
Data Cleaning and Validation
        ↓
Analysis-Ready Dataset
        ↓
Clinical Interpretation and Reporting

This ordering matters.

If governance is skipped, later steps may create harm even when the technical workflow is correct.

For example, a dashboard that displays rare diagnoses by facility may accidentally identify patients in small communities.

A model trained on historical treatment patterns may reproduce inequities if the original care patterns were biased.

A table with dates of admission, age, and diagnosis may appear harmless, but may still be re-identifiable when combined with other information.

Core Concepts

Several terms are often used together, but they are not the same.

Privacy

Privacy concerns a patient’s right to control how personal information is collected, used, shared, and disclosed.

A privacy question asks:

Should this information be used in this way?

Confidentiality

Confidentiality concerns the duty of people and institutions to protect information that has been entrusted to them.

A confidentiality question asks:

Are we protecting the information we were trusted to hold?

Security

Security concerns the technical and operational controls that prevent unauthorized access, loss, misuse, or exposure.

A security question asks:

Can unauthorized people access, alter, or extract these data?

Ethics

Ethics concerns whether the work is fair, respectful, justified, transparent, and beneficial relative to its risks.

An ethics question asks:

Even if this is technically and legally possible, is it responsible?

Common Clinical Data Risks

Clinical datasets can create risk in several ways.

Some risks are obvious.

Others emerge only after data are linked, filtered, visualized, or modeled.

Risk	Example	Why It Matters
Direct identification	Names, phone numbers, medical record numbers	Immediately reveals patient identity
Indirect identification	Age, dates, location, rare diagnosis	Can identify someone when combined with other data
Sensitive attribute exposure	HIV status, pregnancy outcome, mental health diagnosis	May cause stigma, discrimination, or harm
Small cell disclosure	Reporting 1 or 2 cases in a small subgroup	Makes individuals easier to infer
Purpose drift	Data collected for care reused for unrelated analysis	May violate trust or permissions
Algorithmic bias	Model learns from unequal historical care access	May amplify inequity
Misleading interpretation	Association presented as causal effect	May influence poor clinical decisions

A responsible workflow anticipates these risks before analysis begins.

Data Minimization

One of the strongest privacy principles is simple:

Use only the data needed for the question.

This is called data minimization.

If date of birth is not needed, use age group.

If exact visit date is not needed, use month or study day.

If facility name is not needed, use region or coded facility group.

If free-text notes are not needed, exclude them from the analysis dataset.

Data minimization reduces risk without weakening the analysis when done carefully.

Question:
Which age groups have the highest 30-day readmission rate?

Prefer:
age_group, index_admission_date_group, readmission_status

Avoid unless required:
full_date_of_birth, full_address, full medical record number, raw clinical notes

The goal is not to remove useful information blindly.

The goal is to preserve analytical meaning while reducing unnecessary exposure.

De-identification and Pseudonymization

Clinical datasets often need identifiers removed or transformed before analysis.

Two common approaches are de-identification and pseudonymization.

De-identification

De-identification removes or generalizes information so that patients are no longer readily identifiable.

Examples include removing names, replacing exact dates with relative study days, grouping ages, or suppressing rare categories.

Pseudonymization

Pseudonymization replaces direct identifiers with coded identifiers.

For example, a medical record number may be replaced by a generated patient ID.

Original:
medical_record_number = MRN-884921
patient_name = Jane Example

Pseudonymized:
patient_id = P000184
patient_name = removed

Pseudonymized data are still sensitive.

If a key exists that links the coded ID back to the person, the data must still be protected.

Small Cell Protection

Aggregated results can still reveal patient information.

This is especially true when subgroups are small.

Unsafe output:
Facility A, age 80+, rare condition X, mortality count = 1

Safer output:
Facility group, age 65+, rare condition group, count suppressed when n < threshold

Small cell rules vary by institution and setting.

The principle is consistent:

Do not publish or share outputs that make individual patients easy to infer.

A clinical data system should check not only raw datasets, but also tables, figures, dashboards, and reports.

Access Control

Not everyone needs the same level of access.

A modern clinical data system should separate roles.

Role	Typical Access
Data custodian	Raw identifiable data, linkage keys, governance oversight
Data engineer	Controlled access needed for extraction and transformation
Analyst	De-identified or limited dataset needed for analysis
Clinical reviewer	Results, definitions, interpretation context
External collaborator	Approved limited outputs or governed shared dataset

Access should follow the least privilege principle.

This means each person receives only the access necessary for their role.

Audit Trails and Reproducibility

Governance and reproducibility support each other.

A reproducible clinical workflow should record:

where the data came from,
when the data were extracted,
who had access,
which transformations were applied,
which scripts produced which outputs,
and which version of the dataset supported the final report.

This does not mean exposing private information in logs.

Logs should document workflow behavior without leaking patient details.

Good log entry:
2026-06-27 09:15:03 | validation complete | input rows: 1204 | output rows: 1188

Unsafe log entry:
2026-06-27 09:15:03 | removed patient John Example, MRN-884921

Clinical reproducibility must be privacy-aware.

Ethics in Clinical Analysis

Ethical clinical analysis requires more than compliance.

A legally permitted analysis can still be misleading, unfair, or harmful.

Before producing claims, analysts should ask:

Is the clinical question meaningful?
Are the data appropriate for the question?
Are important patient groups missing or underrepresented?
Could the analysis reinforce unequal care patterns?
Are limitations clearly stated?
Could results be misused outside their intended context?
Who should review the interpretation before it is shared?

This is especially important for predictive models and decision-support tools.

A model that predicts risk is not automatically a clinical recommendation.

A dashboard that shows variation is not automatically evidence of poor care.

A statistically significant association is not automatically causal.

Responsible Use of Modern Tools

Modern tools can make clinical workflows faster and more powerful.

They can also make errors scale faster.

Tools such as DuckDB, Arrow, Polars, tidyverse, Plotly, Altair, and dashboard frameworks are useful because they support efficient, transparent, and reproducible work.

But tooling does not replace governance.

A modern clinical data system should combine strong tools with strong boundaries.

Modern clinical data workflow:
- structured project folders
- scripted data checks
- reproducible transformations
- privacy-aware outputs
- reviewed clinical definitions
- documented limitations
- controlled sharing

The safest system is not the one with the most advanced technology.

It is the one where technology, clinical judgment, governance, and ethics work together.

Governance Checklist

Before moving clinical data into analysis, ask:

What is the approved purpose of this analysis?
Which data sources are being used?
Are identifiers removed, transformed, or protected?
Is the dataset limited to the variables needed?
Are small cells protected in outputs?
Are access permissions appropriate?
Are transformations scripted and documented?
Are clinical definitions reviewed?
Are limitations visible in the final report?
Is there a plan for secure storage, sharing, and disposal?

If these questions cannot be answered, the dataset is not yet analysis-ready.

Chapter Summary

Clinical data governance is not separate from clinical data science.

It is one of the foundations that makes clinical analysis trustworthy.

Privacy protects patients.

Security protects systems.

Consent and permissions define appropriate use.

Ethics keeps the work connected to fairness, respect, and responsible interpretation.

As we move from foundations into clinical data inputs, every dataset should be viewed through this lens:

Clinical data analysis is only useful when it is technically sound, clinically meaningful, and responsibly governed.

Transition to Part II

Part I introduced the clinical data system, the major types of healthcare data, how clinical questions become cohorts, and why governance must come before analysis.

Part II now moves into the practical input tables that make clinical analysis possible.

We begin with patient demographics and encounters.